Sisram Medical Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Sisram Medical stock has a consensus rating of "Strong Buy" and an average price target of $4.40. The average 1-year stock price forecast is 84.87% higher than the current stock price, while the lowest is $4.30 (+80.67%) and the highest is $4.51 (+89.50%).

Price Target: $4.40 (+84.87%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.30	$4.40	$4.40	$4.51
Change	+80.67%	+84.87%	+84.87%	+89.50%

* Price targets were last updated on Mar 26, 2026.

Analyst Ratings

The average analyst rating for Sisram Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Aug '25	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	4	4	2	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst CICC No rating	CICC	Buy Maintains $4.50	Buy	Maintains	$4.50	+89.08%	Mar 26, 2026

Financial Forecast

Revenue This Year

404.00M

from 365.35M

10.58%

from 365.35M

Revenue Next Year

447.00M

from 404.00M

10.64%

from 404.00M

EPS This Year

0.07

from 0.07

11.20%

from 0.07

EPS Next Year

0.09

from 0.07

16.33%

from 0.07

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	294.29M	354.48M	359.29M	349.11M	365.35M	404.00M
Revenue Growth	81.56%	20.45%	1.36%	-2.83%	4.65%	10.58%
Gross Profit	166.86M	202.23M	219.53M	216.68M	215.14M	237.55M
Gross Margin	56.70%	57.05%	61.10%	62.07%	58.89%	58.80%
Operating Income	42.76M	45.41M	38.03M	27.68M	27.03M	36.00M
Net Income	31.25M	40.17M	31.50M	25.13M	19.02M	25.00M
EPS	-	-	-	-	0.07	0.07
EPS Growth	-	-	-	-	23.32%	11.20%
Forward PE	11.88	11.88	11.88	11.88	11.88	4.13
Dividend / Share	0.02	0.02	0.02	0.02	0.01	0.02
Dividend Growth	-	10.20%	-8.84%	-19.80%	-24.76%	63.87%
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	404.0M
Avg	404.0M
Low	404.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	10.6%
Avg	10.6%
Low	10.6%

EPS Forecast

EPS	2026	2027	2028
High	0.07
Avg	0.07
Low	0.07

EPS Growth

EPS Growth	2026	2027	2028
High	12.0%
Avg	11.2%
Low	10.4%